Production (Stage)
Instil Bio, Inc.
TIL
$35.50
$2.617.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -27.06% | 16.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.86% | 36.50% | |||
| Operating Income | 5.86% | -36.50% | |||
| Income Before Tax | -137.07% | 48.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -137.07% | 48.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -137.07% | 48.33% | |||
| EBIT | 5.86% | -36.50% | |||
| EBITDA | 4.50% | -41.21% | |||
| EPS Basic | -136.84% | 48.50% | |||
| Normalized Basic EPS | 21.69% | -44.57% | |||
| EPS Diluted | -136.84% | 48.50% | |||
| Normalized Diluted EPS | 21.69% | -44.57% | |||
| Average Basic Shares Outstanding | 0.10% | 0.32% | |||
| Average Diluted Shares Outstanding | 0.10% | 0.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||